MARKET

DNLI

DNLI

Denali
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.26
+0.08
+0.44%
After Hours: 18.26 0 0.00% 16:00 12/06 EST
OPEN
18.26
PREV CLOSE
18.18
HIGH
18.57
LOW
17.97
VOLUME
317.11K
TURNOVER
--
52 WEEK HIGH
28.87
52 WEEK LOW
14.24
MARKET CAP
1.75B
P/E (TTM)
-26.7781
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DNLI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

DNLI News

  • Options Traders Expect Huge Moves in Denali (DNLI) Stock
  • Zacks.4d ago
  • 2 Biotech Stocks Fighting Alzheimer�s Disease to Own Now
  • MotleyFool.com.11/09 12:00
  • Denali Therapeutics EPS beats by $0.09, beats on revenue
  • seekingalpha.11/07 03:21
  • Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Tops Revenue Estimates
  • Zacks.11/07 00:25

More

Industry

Biotechnology & Medical Research
+0.66%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About DNLI

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeutics, based on scientific insights into the genetic causes and biological processes underlying neurodegenerative disease. The Company has selected approximately four specific pathways that are implicated as triggers or effectors of neurodegeneration, including degenogenes (genes that cause neurodegenerative disease when mutated), defective intracellular trafficking, glial dysfunction and axon degeneration. The Company’s development programs include Lysosomal Function Pathway, Glial Biology Pathway, and Cellular Homeostasis Pathway. Its product pipeline includes drug candidates such as DNL201, DNL 151, ATV:aSyn, ETV:IDS, DNL747, and ATV:TREM2.
More

Webull offers Denali Therapeutics Inc (DNLI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.